Hwg Holdings LP Has Decreased Acadia Pharmaceuticalsinc Com (ACAD) Position; 2 Analysts Bullish Napco Security Technologies, Inc. (NSSC)

May 24, 2018 - By Ash

Napco Security Technologies, Inc. (NASDAQ:NSSC) Logo

Hwg Holdings Lp decreased Acadia Pharmaceuticalsinc Com (ACAD) stake by 98.61% reported in 2017Q4 SEC filing. Hwg Holdings Lp sold 32,540 shares as Acadia Pharmaceuticalsinc Com (ACAD)’s stock declined 22.49%. The Hwg Holdings Lp holds 460 shares with $14,000 value, down from 33,000 last quarter. Acadia Pharmaceuticalsinc Com now has $2.12B valuation. The stock decreased 1.45% or $0.25 during the last trading session, reaching $17. About 2.86 million shares traded. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 36.38% since May 24, 2017 and is downtrending. It has underperformed by 47.93% the S&P500.

Among 2 analysts covering NAPCO Security Technologies (NASDAQ:NSSC), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. NAPCO Security Technologies had 10 analyst reports since September 9, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, November 6 by Canaccord Genuity. The firm earned “Buy” rating on Wednesday, July 19 by Canaccord Genuity. As per Thursday, December 28, the company rating was maintained by Canaccord Genuity. Canaccord Genuity maintained Napco Security Technologies, Inc. (NASDAQ:NSSC) rating on Wednesday, July 12. Canaccord Genuity has “Buy” rating and $1200 target. The firm earned “Buy” rating on Monday, February 5 by Canaccord Genuity. Benchmark initiated Napco Security Technologies, Inc. (NASDAQ:NSSC) on Thursday, January 12 with “Buy” rating. The firm has “Buy” rating given on Monday, May 7 by Canaccord Genuity. The company was maintained on Thursday, August 10 by Canaccord Genuity. See Napco Security Technologies, Inc. (NASDAQ:NSSC) latest ratings:

07/05/2018 Broker: Canaccord Genuity Rating: Buy New Target: $14.0000 Maintain
05/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $14.0 Maintain
28/12/2017 Broker: Canaccord Genuity Rating: Buy New Target: $14.0 Maintain

Analysts await ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to report earnings on August, 14. They expect $-0.46 EPS, up 16.36% or $0.09 from last year’s $-0.55 per share. After $-0.44 actual EPS reported by ACADIA Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 4.55% negative EPS growth.

More news for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) were recently published by: Fool.com, which released: “Is Acadia Pharmaceuticals (ACAD) a Buy?” on May 23, 2018. Seekingalpha.com‘s article titled: “Acadia: Damn The Torpedoes, Full Speed Ahead” and published on May 07, 2018 is yet another important article.

Since January 2, 2018, it had 1 insider buy, and 3 sales for $3.94 million activity. Baity Glenn also sold $1.18 million worth of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on Monday, January 29. SOLAND DANIEL B also bought $234,910 worth of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares. Brege Laura sold 25,000 shares worth $751,543.

Investors sentiment increased to 1.26 in Q4 2017. Its up 0.25, from 1.01 in 2017Q3. It is positive, as 30 investors sold ACAD shares while 47 reduced holdings. 32 funds opened positions while 65 raised stakes. 117.35 million shares or 3.35% more from 113.55 million shares in 2017Q3 were reported. Glg Prtnrs Lp has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Contravisory Investment invested 0% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Tci Wealth Advisors holds 0.02% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 1,750 shares. Lpl Financial reported 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Parametric Port Associate Ltd Co stated it has 42,147 shares or 0% of all its holdings. Garrison Bradford has 1.85% invested in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Stevens Mngmt LP has 58,517 shares for 0.07% of their portfolio. Sweden-based Rhenman And Partners Asset Mngmt Ab has invested 1.38% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Citigroup accumulated 73,031 shares or 0% of the stock. Orbimed Advsr Limited Liability Corp has invested 0.32% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Reilly Finance Advsr Ltd Liability Co accumulated 0.01% or 1,425 shares. Tiaa Cref Investment Management Ltd Co reported 0.01% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). 570 were accumulated by Architects. Zacks Investment Mngmt accumulated 0.02% or 31,370 shares. Amer Research Management owns 100 shares.

Among 12 analysts covering ACADIA Pharmaceuticals (NASDAQ:ACAD), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. ACADIA Pharmaceuticals had 35 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, October 10 by Jefferies. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) earned “Neutral” rating by Piper Jaffray on Friday, August 7. The rating was maintained by H.C. Wainwright on Wednesday, November 8 with “Buy”. The firm earned “Buy” rating on Tuesday, November 7 by Cowen & Co. The rating was maintained by Jefferies with “Buy” on Thursday, July 27. As per Sunday, August 9, the company rating was maintained by Cowen & Co. The company was maintained on Thursday, October 5 by Piper Jaffray. The stock has “Buy” rating by Needham on Tuesday, April 10. JP Morgan maintained ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on Friday, September 4 with “Buy” rating. The firm has “Overweight” rating by Piper Jaffray given on Friday, January 22.

Hwg Holdings Lp increased Vanguard Specialized Fundsdiv (VIG) stake by 14,513 shares to 86,847 valued at $8.86 million in 2017Q4. It also upped Align Technology Inc Com (NASDAQ:ALGN) stake by 2,607 shares and now owns 3,057 shares. Ishares Russell 1000Value Etf (IWD) was raised too.

Since May 16, 2018, it had 0 insider buys, and 1 insider sale for $79,448 activity. HEVIA JORGE had sold 6,750 shares worth $79,448.

Napco Security Technologies, Inc. manufactures and sells security products and software worldwide. The company has market cap of $224.60 million. The firm offers access control systems, door security products, intrusion and fire alarm systems, and video surveillance systems for commercial, residential, institutional, industrial, and governmental applications. It has a 36.36 P/E ratio. The Company’s access control systems include various types of identification readers, control panels, PC computers, and electronically activated door-locking devices; and door locking devices comprise microprocessor electronic door locks with push button, card readers and bio-metric operation, door alarms, mechanical door locks, and simple dead bolt locks.

Investors sentiment increased to 1.94 in Q4 2017. Its up 0.59, from 1.35 in 2017Q3. It increased, as 6 investors sold Napco Security Technologies, Inc. shares while 10 reduced holdings. 13 funds opened positions while 18 raised stakes. 5.39 million shares or 0.02% less from 5.40 million shares in 2017Q3 were reported. Raffles Assocs Lp reported 166,186 shares. Vanguard owns 438,008 shares for 0% of their portfolio. Thompson Davis And Communication Inc stated it has 0.02% of its portfolio in Napco Security Technologies, Inc. (NASDAQ:NSSC). New York-based Amer Interest Grp Inc has invested 0% in Napco Security Technologies, Inc. (NASDAQ:NSSC). Deutsche Bankshares Ag has 62,789 shares. Wasatch Advsrs Inc reported 604,569 shares. New York-based Jpmorgan Chase And has invested 0% in Napco Security Technologies, Inc. (NASDAQ:NSSC). Envestnet Asset Mgmt holds 0% or 1,898 shares. Ameritas Invest Partners Incorporated holds 0% or 1,045 shares in its portfolio. Price T Rowe Assoc Md reported 15,548 shares. California Public Employees Retirement has 86,060 shares for 0% of their portfolio. Us National Bank & Trust De invested in 0% or 7,300 shares. Gsa Ptnrs Llp has invested 0.01% in Napco Security Technologies, Inc. (NASDAQ:NSSC). 142,761 are owned by Northern. Wedge Cap Mgmt L Limited Partnership Nc reported 31,900 shares stake.

Napco Security Technologies, Inc. (NASDAQ:NSSC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts